A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

Hospital for Children and Adolescents, Finland

Status: Invitation-only

Conditions: Kallmann Syndrome

Treatments: Drug: Short withdrawal of testosterone, gonadotropins or estrogenic compounds (see below)

Study type: Interventional

Funder types: Other

Identifiers

NCT00623116

231408

286/E7/2007

Details and patient eligibility

About

Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.

Full description

Kallmann syndrome is comprised of idiopathic hypogonadotropic hypogonadism and anosmia (inability to smell). Associated phenotypes may include cryptorchidism, microphallus, bone deformations, mirror movements, hearing loss and infertility. Objective is to characterize epidemiology, clinical and genetic features of Kallmann syndrome in Finland.

Enrollment: 50 estimated patients

Sex: All

Ages: 15+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Kallmann syndrome
• Age 15 yrs or more

Exclusion criteria

• Severe mental retardation

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)